658 related articles for article (PubMed ID: 19519285)
1. Emerging drugs for acute graft-versus-host disease.
Khaled Y; Reddy P; Krijanovski O
Expert Opin Emerg Drugs; 2009 Jun; 14(2):219-32. PubMed ID: 19519285
[TBL] [Abstract][Full Text] [Related]
2. Graft-versus-host disease.
Choi S; Reddy P
Panminerva Med; 2010 Jun; 52(2):111-24. PubMed ID: 20517195
[TBL] [Abstract][Full Text] [Related]
3. Harnessing dendritic cells to improve allogeneic hematopoietic cell transplantation outcome.
Hashimoto D; Merad M
Semin Immunol; 2011 Feb; 23(1):50-7. PubMed ID: 21316261
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model.
Vanclée A; Lutgens LC; Oving EB; Deutz NE; Gijbels MJ; Schouten HC; Bos GM
Bone Marrow Transplant; 2005 Nov; 36(10):907-15. PubMed ID: 16151417
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation.
Saito TI; Rubio MT; Sykes M
Exp Hematol; 2006 Sep; 34(9):1271-7. PubMed ID: 16939820
[TBL] [Abstract][Full Text] [Related]
6. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
7. Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.
Johnston L
Best Pract Res Clin Haematol; 2008 Jun; 21(2):177-92. PubMed ID: 18503985
[TBL] [Abstract][Full Text] [Related]
8. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
9. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
Gaziev D; Galimberti M; Lucarelli G; Polchi P
Bone Marrow Transplant; 2000 Apr; 25(7):689-96. PubMed ID: 10745252
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Remberger M
Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
12. Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Hiemenz JW
Semin Hematol; 2009 Jul; 46(3):289-312. PubMed ID: 19549581
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host disease: emerging concepts in prevention and therapy.
Dean RM; Bishop MR
Curr Hematol Rep; 2003 Jul; 2(4):287-94. PubMed ID: 12901325
[TBL] [Abstract][Full Text] [Related]
14. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
15. Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation: a clinical review.
Pollack SM; O'Connor TP; Hashash J; Tabbara IA
Am J Clin Oncol; 2009 Dec; 32(6):618-28. PubMed ID: 19593085
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis and treatment of acute graft-versus-host disease.
Chao NJ; Chen BJ
Semin Hematol; 2006 Jan; 43(1):32-41. PubMed ID: 16412787
[TBL] [Abstract][Full Text] [Related]
18. Nonmyeloablative allogeneic stem cell transplantation for acute leukemia.
Laport GG
Curr Hematol Rep; 2003 Jan; 2(1):49-56. PubMed ID: 12901154
[TBL] [Abstract][Full Text] [Related]
19. Many faces of graft-versus-host disease.
Peñas PF; Zaman S
Australas J Dermatol; 2010 Feb; 51(1):1-10; quiz 11. PubMed ID: 20148830
[TBL] [Abstract][Full Text] [Related]
20. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
Loren AW; Porter DL
Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
